Oncotelic Bets on AI for Pharma Compliance

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is positioning itself within the growing AI-driven automated compliance space, as highlighted in an editorial by AINewsWire. The company operates at the intersection of biotechnology and advanced digital systems. Pharmaceutical manufacturers are increasingly integrating AI directly into production workflows as a continuous compliance layer, replacing traditional retrospective audits with real-time monitoring and validation aligned with Good Manufacturing Practice requirements.